logo

Rumi Scientific

Rumi Scientific's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Rumi Scientific's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@rumiscientific.com
 

Ilona Nemeth

Ilona Nemeth, MBA

 

Ms. Nemeth has been an executive in high-growth businesses as well as managing an investment portfolio. She was the founding Chief Executive Officer of Rumi Scientific, guiding the company at its inception and helping shape its early vision and strategic direction. Prior to overseeing several business areas within DoubleClick, (an original Internet ad – serving technology company, now owned by Google), she headed high-tech materials Strategy & Acquisitions for AlliedSignal (now Honeywell) and worked before that at Goldman Sachs.


Ms. Nemeth received an MBA from INSEAD in France, and graduated Phi Beta Kappa from Columbia University. She has served on several councils and advisory boards, including technology-provider Catchpoint, at Rockefeller University, the INSEAD Alumni Fund and the American Advisory Board of the London Symphony Orchestra.


I would like to learn about Rumi Scientific’s novel discoveries to treat genetic diseases.